Literature DB >> 33381648

Letter to the Editor: Possible Drug-Drug Interactions Between Cannabinoids and Candidate COVID-19 Drugs.

M Hunter Land1, Laura MacNair1, Brian F Thomas1, Erica N Peters1, Marcel O Bonn-Miller1,2.   

Abstract

Entities:  

Year:  2020        PMID： 33381648      PMCID： PMC7759270          DOI： 10.1089/can.2020.0054

Source DB:  PubMed          Journal:  Cannabis Cannabinoid Res        ISSN： 2378-8763


× No keyword cloud information.
  6 in total

Review 1.  Cannabis and Cannabinoids: Kinetics and Interactions.

Authors:  Brian C Foster; Hanan Abramovici; Cory S Harris
Journal:  Am J Med       Date:  2019-05-30       Impact factor: 4.965

2.  Cannabidiol differentially regulates basal and LPS-induced inflammatory responses in macrophages, lung epithelial cells, and fibroblasts.

Authors:  Thivanka Muthumalage; Irfan Rahman
Journal:  Toxicol Appl Pharmacol       Date:  2019-08-19       Impact factor: 4.219

3.  Effect of the psychoactive metabolite of marijuana, delta 9-tetrahydrocannabinol (THC), on the synthesis of tumor necrosis factor by human large granular lymphocytes.

Authors:  D I Kusher; L O Dawson; A C Taylor; J Y Djeu
Journal:  Cell Immunol       Date:  1994-03       Impact factor: 4.868

4.  Evaluation of Serum Cytokines Levels and the Role of Cannabidiol Treatment in Animal Model of Asthma.

Authors:  Francieli Vuolo; Fabricia Petronilho; Beatriz Sonai; Cristiane Ritter; Jaime E C Hallak; Antonio Waldo Zuardi; José A Crippa; Felipe Dal-Pizzol
Journal:  Mediators Inflamm       Date:  2015-05-25       Impact factor: 4.711

Review 5.  Immune Responses Regulated by Cannabidiol.

Authors:  James M Nichols; Barbara L F Kaplan
Journal:  Cannabis Cannabinoid Res       Date:  2020-02-27

Review 6.  Coronavirus Disease 2019 Treatment: A Review of Early and Emerging Options.

Authors:  Erin K McCreary; Jason M Pogue
Journal:  Open Forum Infect Dis       Date:  2020-03-23       Impact factor: 3.835
  6 in total
  2 in total

1.  Commentary: Use of Cannabinoids to Treat Acute Respiratory Distress Syndrome and Cytokine Storm Associated With Coronavirus Disease-2019.

Authors:  Maurizio Bifulco; Donatella Fiore; Chiara Piscopo; Patrizia Gazzerro; Maria Chiara Proto
Journal:  Front Pharmacol       Date:  2021-04-12       Impact factor: 5.810

2.  Cannabis/Cannabinoids for Treating COVID-19 Associated Neuropsychiatric Complications.

Authors:  Jag H Khalsa; Sanjay B Maggirwar; Greg Bunt
Journal:  J Neuroimmune Pharmacol       Date:  2021-10-16       Impact factor: 7.285
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.